Therapeutic Goods Amendment Regulations 2001 (No. 4)

Administered by Department of Health, Disability and Ageing

Legislation au F2001B00580 Regulations Not in force Legislative Instrument

Legislation content

Therapeutic Goods Amendment Regulations 2001 (No. 4) 2001 No. 343

EXPLANATORY STATEMENT

STATUTORY RULES 2001 No. 343

Issued by authority of the Minister for Health and Ageing

Therapeutic Goods Act 1989

Therapeutic Goods Amendment Regulations 2001 (No. 4)

Subsection 63(1) of the Therapeutic Goods Act 1989 (the Act) provides that the Governor-General may make Regulations prescribing, among other things, matters necessary or convenient for carrying out or giving effect to the Act.

Subsection 18(1) of the Act provides that the Regulations may, subject to such conditions as may be specified, exempt all therapeutic goods or specified goods or a specified class of goods from the operation of Part 3 of the Act. Part 3, inter alia, requires the entry of therapeutic goods on the Australian Register of Therapeutic Goods (ARTG) prior to their importation, exportation, manufacture or supply in Australia.

The purpose of the amendments to the Regulations is to enable the importation and supply of essential unapproved therapeutic goods, such as antibiotics, vaccines and chemical antidotes, in exceptional circumstances such as where there is a terrorist threat of a chemical, biological or radiological nature. The rarity of likely agents used in these terrorist threats is such that some of the recommended treatments are not registered in Australia. Potentially, many people would require emergency treatment to counteract the effect of biological or chemical agents and such treatments would need to be supplied with minimum delay. These amendments constitute a critical aspect of Australia's preparedness to respond to terrorism threats in the form of chemical and biological weapons. They allow immediate action to be taken to ensure supply of therapeutic goods that are appropriate to meet threats as they arise or that are anticipated because of incidents overseas.

The amending Regulations therefore:

       Insert new items in Schedule 5A exempting from inclusion in the ARTG the importation and supply of Combopen Autoinjector, Atropen Autoinjector and smallpox vaccine, subject to specified conditions which include approval of the supply in writing by the Secretary; and

       Exempt therapeutic goods that are to be manufactured or imported by or on behalf of the Department and which have been certified by the Secretary to be emergency supplies that are essential to the protection of public health. The supply of these exempt goods is also subject to specified conditions. This amendment enables quick action to be taken as appropriate therapeutic goods are identified to combat a threat or as circumstances change.

Details of the Regulations are set out in the Attachment.

The Regulations set out in Schedule 1 are taken to have commenced on 30 September 2001 and the Regulations set out in Schedule 2 commence on gazettal.

Retrospective operation of the new item in Schedule 1 is necessary to validate the importation of products that have already been brought into Australia in anticipation of possible terrorist activity. The retrospective operation does not disadvantage any person's rights because without the amendment to the Regulations there is no right to import and supply the products in Australia as exempt goods and will thus not contravene subsection 48(2) of the Acts Interpretation Act 1901. The amendment will enable persons who have already stockpiled this product to legally supply it, should the need arise, subject to conditions imposed by the Secretary, without infringing the provisions of the Therapeutic Goods Act.

ATTACHMENT

Therapeutic Goods Amendment Regulations 2001 (No. 4)

Regulation 1 states that the title of these Regulations will be the Therapeutic Goods Amendment Regulations 2001 (No. 4)

Regulation 2 provides that Regulations 1 to 3 and Schedule 1 are taken to have commenced on 30 September 2001 and that Schedule 2 will commence on gazettal. Retrospective operation of the new item in Schedule 1 is necessary to validate the importation of some of these therapeutic goods that have already been brought into Australia in anticipation of possible terrorist activity.

Regulation 3 provides that Schedules 1 and 2 amend the Therapeutic Goods Regulations 1990. Schedule 1 sets out the amendment that is taken to have commenced on 30 September 2001 and Schedule 2 sets out the amendments that commence on gazettal.

Schedule 1 - amendment taken to have commenced on 30 September 2001

Item 1 inserts into Schedule 5A a new item 9 the effect of which is to exempt from Part 3 of the Act the therapeutic goods Combopen Autoinjector and Atropen Autoinjector. This exemption is subject to four conditions - the goods must be imported from a specified source; supply must be approved in writing by the Secretary; the goods must be stored, supplied or used in accordance with any specified conditions; and, at the end of the period for which the exemption applies, any remaining goods must be destroyed or returned to the consignor.

Schedule 2 - amendments commencing on gazettal

Item 1 inserts into regulation 12 two new subsections that set out sunset provisions for the new exemptions provided by these amendments. The new items exempting Combopen Autoinjector, Atropen Autoinjector and smallpox vaccine will cease to apply at the end of 2002. The new item allowing the Secretary to certify therapeutic goods as emergency supplies will cease to apply at the end of June 2002. This item recognises that these amendments involve emergency powers that are necessary as short-term measures to counter possible threats to public health.

Item 2 amends regulation 47 to allow external delegation of the Secretary's power to approve supply under items 9 or 11 (but not the power to certify goods as emergency supplies). This power may be delegated to the chief health officer, the CEO or a senior medical officer of a State or Territory Department that has responsibility for health matters.

Item 3 inserts into Schedule 5A two new items.

New item 10 allows the importation of smallpox vaccine subject to four conditions - the vaccine must be from a source approved in writing by the Secretary; supply must be approved in writing by the Secretary; storage, supply or use must be in accordance with any specified conditions; and, at the end of the period for which the exemption applies, remaining vaccine must be destroyed or returned to the consignor.

New item 11 allows the supply of goods that are manufactured or imported by or on behalf of the Department where they have been certified by the Secretary as emergency supplies. The supply is subject to three conditions - the supply must be approved in writing by the Secretary; the goods must be stored, supplied or used in accordance with any specified conditions; and, at the end of the period for which the exemption applies, remaining goods must be destroyed or returned to the consignor.

 

Overview

The Therapeutic Goods Amendment Regulations 2001 (No. 4) were enacted to address the need for expeditious importation and supply of essential therapeutic goods in exceptional circumstances, such as terrorist threats involving chemical, biological, or radiological agents. These regulations amend the Therapeutic Goods Regulations 1990 under the authority of the Therapeutic Goods Act 1989. They aim to ensure that critical therapeutic goods, including antibiotics, vaccines, and antidotes, can be imported and supplied without delay in situations where such goods are not yet approved for use in Australia. The policy objective of these amendments is to bolster Australia's preparedness and response capability against potential terrorist threats, thereby safeguarding public health. The regulations provide for specific exemptions from the requirement to register therapeutic goods on the Australian Register of Therapeutic Goods, subject to conditions set by the Secretary, including approval for supply and specified conditions for storage, supply, or use.

Scope and Application

The Therapeutic Goods Amendment Regulations 2001 (No. 4) amends the Therapeutic Goods Regulations 1990 to exempt certain therapeutic goods from the registration requirements under the Therapeutic Goods Act 1989. These amendments apply to the importation and supply of specific therapeutic goods, such as Combopen Autoinjector, Atropen Autoinjector, and smallpox vaccine, as well as therapeutic goods that have been certified as emergency supplies by the Secretary. These exemptions are subject to conditions, including the approval of supply by the Secretary, adherence to specified conditions for storage, supply, or use, and the destruction or return of any remaining goods at the end of the exemption period. The amendments enable quick action to be taken in response to potential chemical, biological, or radiological terrorist threats, ensuring the availability of necessary therapeutic goods to protect public health. The Regulations provide for both retrospective and prospective application, with certain provisions taken to have commenced on 30 September 2001, and others commencing on gazettal. The amendments are temporary, with sunset provisions set to end at the close of 2002 for the exemptions related to Combopen Autoinjector, Atropen Autoinjector, and smallpox vaccine, and at the end of June 2002 for the exemption concerning emergency supplies. These measures are designed to address urgent public health needs while maintaining regulatory oversight.

Key Provisions

The Therapeutic Goods Amendment Regulations 2001 (No. 4) introduce significant changes to the Therapeutic Goods Act 1989, particularly in relation to the importation and supply of therapeutic goods in exceptional circumstances, such as in response to a terrorist threat involving chemical, biological, or radiological agents (regs 1, 2). These amendments are designed to ensure that essential therapeutic goods, such as antibiotics, vaccines, and antidotes, can be rapidly supplied in emergencies, even if they have not been approved or registered in Australia (reg 1, item 1). This is achieved by exempting certain therapeutic goods from the requirement to be entered on the Australian Register of Therapeutic Goods (ARTG) before they are imported, exported, manufactured, or supplied in Australia (s 18(1)). The amendments impose specific conditions on the importation and supply of the exempted therapeutic goods. For example, Combopen Autoinjector and Atropen Autoinjector can be imported and supplied only if they meet criteria such as being sourced from a specified source, obtaining written approval from the Secretary, and adhering to any additional conditions specified by the Secretary (reg 1, item 1, Schedule 5A, item 9). Similarly, the importation of smallpox vaccine is subject to conditions such as approval from the Secretary and adherence to specified storage, supply, and use conditions (reg 1, item 1, Schedule 5A, item 10). Additionally, therapeutic goods that are manufactured or imported by or on behalf of the Department and certified by the Secretary as emergency supplies can be supplied under certain conditions (reg 1, item 1, Schedule 5A, item 11). The supply of these goods must also be approved in writing by the Secretary and must comply with any specified conditions, including the destruction or return of any remaining goods at the end of the exemption period (reg 1, item 1, Schedule 5A, item 11). The Regulations also establish specific obligations and requirements for parties involved in the importation and supply of these therapeutic goods. These obligations include ensuring that the goods are sourced, stored, supplied, and used in accordance with the conditions set by the Secretary (reg 1, item 1, Schedule 5A, items 9, 10, and 11). Furthermore, the Regulations provide for the retrospective operation of the amendments to validate the importation of goods that have already been brought into Australia in anticipation of possible terrorist activity (reg 2). The Regulations stipulate that any remaining goods at the end of the exemption period must be destroyed or returned to the consignor (reg 1, item 1, Schedule 5A, items 9, 10, and 11). The amendments also include sunset provisions, with the exemptions for Combopen Autoinjector, Atropen Autoinjector, and smallpox vaccine ceasing at the end of 2002 and the exemption for emergency supplies ceasing at the end of June 2002 (reg 1, item 1, Schedule 2, item 1). Failure to comply with the conditions set out in the Regulations can result in civil or criminal penalties. While the specific penalties are not detailed in the Regulations, breaches of the Therapeutic Goods Act 1989 can generally result in fines and, in some cases, imprisonment. The severity of the penalty often depends on the nature and extent of the breach, with more serious offences potentially attracting higher penalties. The Regulations' focus on ensuring the rapid and safe supply of therapeutic goods in emergency situations underscores the importance of adhering to the specified conditions to protect public health.

Legal classification tags

Area of Law
Health Law
Instrument
Regulation
Concepts
Regulatory Standards
Emergency Powers
Delegated & Subordinate Legislation

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.